Indication
P47
1 clinical trial
1 product
Clinical trial
A Phase I/II, Non-Randomized, Open-Label Study of pCCLCHIM-p47 (Lentiviral Vector Transduced CD34+ Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)Status: , Estimated PCD: 2027-03-31